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ABSTRACT  
A Schiff base ligand 2-[(1E)-N-{2-[(2-{(Z)-[1-(2-hydroxyphenyl) ethylidene] amino}ethyl)amino]ethyl} ethanimidoyl]phenol L was hydrolyzed 
by copper cation which lead to formation of 8,8-dichloro-2H,3H,5H,6H-1,3-diaza-2-cupracyclopenta[1,3-a]1,3-diaza-2-cupracyclopentane 
hydrate (Complex), characterized by UV, IR, Powder XRD and by elemental analysis. In vitro antioxidant and anticoagulant, activities of L were 
evaluated. Antioxidant potential of L was assessed by DPPH scavenging, β-carotene bleaching test, hydroxyl radical scavenging method, ABTS 
radical scavenging test, and by reducing power test. In vitro anticoagulant effect of L at the 84 µg/mL; showed the maximum prolongation of 
plasma recalcification time which is comparable with that of the anticoagulant drug; heparin. In conclusion, results of the present investigation 
indicate that the ligand L can be a potential anticoagulant agent. 
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1. INTRODUCTION 
Schiff bases are products that can be obtained via 
condensation of primary amines with carbonyl compounds 
and were first reported by Schiff in 1864 [1].These 
compounds have been extensively used as ligands in the 
synthesis of metal complexes [2]. In addition, Schiff bases 
represent an important class of organic compounds, 
especially in the fields of medicinal and pharmaceutical 
chemistry [3]. In fact, many Schiff bases display interesting 
pharmacological activities such as antibacterial, antifungal, 
antimalarial, antimicrobial, and anticancer activity [4]. 
Furthermore, their transition-metal complexes were found 
to have interesting bioactivity and play a role as potent drugs 
in the area of pharmacology [5]. Literature survey reveals 
that zinc(II) complex with 4-amino-1H-pyrimidin-2-one, 
diacetyl and glycine Schiff base showed a higher activity 
against C. parapsilosis [6].On the other hand, Schiff bases are 
used for colorimetric detection of Al3+, these detections are 
very important for human health [7]. Furthermore, Schiff 
bases with electron donors (N, O, S…) have structural 
similarities with neutral biological systems and due to the 
presence of an imine (C=N) group, they can be used in 
elucidating the mechanism of transformation of 
rasemination reaction in biological system [8].   
Several research groups have been involved in the synthesis 
and biological screening of Schiff bases [9]. Hranjec et al. 
2011 [10] prepared a series of novel benzimidazole Schiff 
bases as antiproliferative agents. In addition, Ronad [11] and 
coworkers synthesized a series of Schiff bases from 7-amino-
4-methylcoumarin and benzaldehydes, and studied their 
anti-inflammatory and analgesic activities. These researchers 
found that some of the prepared compounds were active, 
even more potent than a reference drug. Due to the presence 
of phenolic groups, phenolic Schiff bases are reported as 
powerful antioxidants and good free radical scavengers [12]; 
antioxidants have the ability to convert free radicals to stable 
molecules. This process safeguard cells from oxidative 
damage which leads to aging and diseases [13],and provide 
protection against cancer-causing and DNA damaging 
radicals [14]. 
We have recently prepared the pentadentate ligand 2,2'-
(((azanediylbis(propane-1,3-diyl))bis(azanylylidene)) 
bis(methanylylidene))diphenol from salicylaldehyde and N1-
(3-aminopropyl)propane-1,3-diamine, along with its metal 
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complexes [15]. Additionally, we have evaluated the 
antioxidant and antibacterial activities of the Schiff base and 
its complexes in vitro. In view of the wide interest in Schiff 
bases, and owing to their biological importance, we have 
prepared the Schiff base 1 from condensation of 2-
hydroxyacetophene with N-(2-aminoethyl)-1,3-
propanediamine. The Schiff base 2-[(1E)-N-{2-[(2-{(Z)-[1-(2-
hydroxy phenyl)ethylidene]amino}ethyl)amino] 
ethyl}ethanimidoyl]phenol, was characterized by a panel of 
spectroscopic techniques such as UV, IR, NMR, and mass 
spectrometry, and by elemental analysis. In addition, the 
antioxidant, and anticoagulant activities of this Schiff base 
were examined. 
2. MATERIALS AND METHODS 
2.1.  Materials  
Each of the following chemicals was purchased and used 
without further purification: 2’-hydroxyacetophenone 
(Aldrich), diethylenetriamine, 2,2’-diphenyl-1-picrylhydrazyl 
(DPPH), β-carotene, linoleic acid, butylated hydroxy toluene 
(BHT), and TWEEN 40 (Sigma–Aldrich). Reactions were 
monitored by thin layer chromatography (TLC) using silica 
gel plates (60 F-254, Merck); plates were visualized under 
UV light. Melting point was measured with a Stuart melting 
point apparatus. Infrared spectra (IR) were obtained, as KBr 
disks, on a Schimadzu FTIR-8400S spectrophotometer. The 
electronic absorption spectra in the 200–900 nm range were 
recorded on a UV-1800Schimadzu UV–visible 
spectrophotometer.1H and 13C NMR spectra were obtained 
with a Bruker-Avance III 500 MHz spectrometer with DMSO-
d6as solvents and TMS as an internal standard. Chemical 
shifts are expressed in δ units, and coupling constants (J-
values) for 1H-1H, are given in Hertz. High resolution mass 
spectrum (HRMS) was acquired by electrospray ionization 
(ESI) technique with the aid of a Bruker APEX-2 instrument. 
The mass spectrum displayed the correct molecular ion peak 
for which the measured high resolution (HRMS) data are in 
good agreement with the calculated value. Elemental 
analysis (C, H, and N) was carried out with a EuroVector 
EA3000 instrument. 
2.2.  Methods 
2.2.1. Synthesis of Schiff base ligand 2-[(1E)-N-{2-[(2-
{(Z)-[1-(2-hydroxyphenyl)ethylidene]amino} 
ethyl)amino] ethyl}ethanimidoyl]phenol, L 
The Schiff base, 2-[(1E)-N-{2-[(2-{(Z)-[1-(2-
hydroxyphenyl)ethylidene]amino}ethyl) 
amino]ethyl}ethanimidoyl]phenol (L), (Scheme1) was 
prepared according to a procedure outlined by Charef et al. 
[16], which involved reaction of diethylenetriamine (1.032 g, 
10.0 mmol) with 2’-hydroxyacetophenone (2.72 g, 20 mmol) 
in 100 mL of absolute ethanol. The mixture was refluxed for 
3h at 50 °C, with stirring. After cooling, the mixture was 
concentrated under reduced pressure to afford the desired 
product as a yellow solid, which was filtered and dried in 
vacuum. 
 
Scheme1. Synthesis of Schiff base L. 
Yield 98%. M.p.: 93-94 οC. UV–Vis (EtOH) λmax (nm) 321, 389. 
IR (KBr, cm–1): νmax: 3453 (br, OH), 1616 (C=N). 1H-NMR 
(500 MHz, DMSO-d6) (ppm): 2.33 (s, 3H, CH3), 2.88 (t, J = 
13.0 Hz, 2H), 3.61 (t, J = 12.6 Hz, 2H), 6.69 (dd, J = 24.9, 16.8 
Hz, 2H), 7.21 (t, J = 14.9 Hz, 1H), 7.57 (d, J = 16.2 Hz, 1H,), 
16.49 (s, 1H, OH). 13C-NMR (75 MHz, DMSO-d6) (ppm): 
14.8(CH3), 49.3 (CH2), 49.9 (CH2), 116.7 (CH), 118.8 (CH), 
119.2 (C), 129.2 (CH), 132.8 (CH), 164.9 (C), 173.2 (C).HRMS 
(EIMS) m/z: calcd. for C20H26N3O2 [M + H]+340.20250, found 
340.20308. Anal.Calcd for C20H25N3O2: C, 70.77; H, 7.42; N, 
12.38. Found: C, 70.69; H, 7.38; N, 12.32%. 
2.2.2. Hydrolysis cleavage of 2-[(1E)-N-{2-[(2-{(Z)-[1-
(2-hydroxyphenyl) ethylidene]amino} ethyl)amino] 
ethyl}ethanimidoyl]phenol, L 
8,8-dichloro-2H,3H,5H,6H-1,3-diaza-2-cupracyclopenta[1,3-
a]1,3-diaza-2-cupracyclopentane hydrate (Complex) was 
formed from the complete hydrolysis of the ligand L, which 
involved reaction of  L (0.002mol, 0.68g) and CuCl2.2H2O 
(0.002mol, 0.34g) in 50 mL of absolute ethanol, the reaction 
mixture was refluxed for 24h at 75°C. After cooling the 
crystalline powder was washed several times with absolute 
ethanol and diethyl ether and dried in vacuum (Scheme 2).  
 
Scheme 2. Hydrolysis cleavage of the ligand L   
Yield 76%. UV–Vis (EtOH) λmax (nm) 247. IR (KBr, cm–1): νmax: 
3276-3243 (br, NH2), Anal.Calcd for C4H15Cl2CuN3O: C, 18.79; 
H, 5.91; N, 16.44. Found: C, 19.53; H, 5.54; N, 16.82%. 
2.3.  In vitro antioxidant activity 
2.3.1. DPPH radical scavenging activity 
A methanolic solution of L or BHT at different concentrations 
(500 µL) was mixed and incubated in the dark for 30 min 
with 500 µL of DPPH solution (0.25 mM), and the absorbance 
was then measured at 517 nm [17]. The DPPH radical 
scavenging activity of L was calculated using the following 
equation:  
                    ( )       (      )      
A0 is the absorbance of the blank and A1 the absorbance of L 
or of butylated hydroxytoluene (BHT) used a standard.  
2.3.2. Β-carotene/linoleic acid bleaching method 
Four milligrams of β-carotene was dissolved in 2 mL of 
chloroform and placed in a 100-mL round-bottom flask. After 
chloroform evaporation, 25 µL of linoleic acid, 200 mg of 
Tween 40, and100 mL oxygenated water were added to the 
flask with vigorous shaking. Aliquots (2.5 mL) of this 
emulsion were added to 350 µL of tested compounds (2 
mg/mL). The absorbance was measured at 470 nm, each 15 
minute for 2h. Inhibition of lipid peroxidation was calculated 
from the equation [18]; 
           ( )    (              )       
Asample is the absorbance of the compound and ABHT is the 
absorbance of BHT (used as a standard). 
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2.3.3. Hydroxyl scavenging activity  
A reaction mixture (1.1mL) containing 500 µL of FeSO4 (1.5 
mM), 350 µL of H2O2 (6 mM), 150 µL of sodium salicylate (20 
mM) and 100 µL of different concentrations of the tested 
compound was made. The mixture was incubated at 37ºC for 
30 min and the absorbance was measured at 562 nm. The 
percentage scavenging effect was calculated from the 
formulae:                     ( )     (     )        
   , where A0is the absorbance of the control (without 
sample), A1is the absorbance in the presence of the sample, 
and A2is the absorbance without sodium salicylate. Ascorbic 
acid was employed as astandard[19]. 
2.3.4. ABTS radical scavenging activity 
An aqueous solution of ABTS (7 mM) was mixed with 
(K2S2O8) solution (2.45 mM), and the mixture was incubated 
at room temperature in the dark for 16 h. The mixture was 
diluted with ethanol to obtain an absorbance of 0.750 ± 
0.025 at 734 nm. Then, 2 mL of this solution was added to 20 
μL of L solution at different concentrations. After 30 min of 
incubation, the ABTS•+ radical scavenging activity was 
calculated using the following equation:  
                    ( )  (          )       
Where AC is the initial concentration of the ABTS•+ and AS is 
absorbance of the remaining concentration of ABTS•+ in the 
presence of L or BHT [20].   
2.3.5. Reducing power test 
To 200µL of sample solution at different concentrations, 200 
µL of 0.2 M phosphate buffer (pH 6.6) and 200 µL of 
potassium ferricyanide (1%) were added. After incubation 
for 20 min at 50ºC, 200 µL of trichloroacetic acid (10%) were 
added, and the reaction mixture was centrifuged for 10 min 
at 1000 rpm. An amount of 200µL of supernatant was mixed 
with 200µL of distilled water and 40 µL of ferric chloride 
(0.1%), and the absorbance was measured at 700 nm. Higher 
absorbance of the reaction mixture indicates greater 
reducing power [21],[22]. 
2.4. Anticoagulant activity by plasma recalcification 
time 
Blood was freshly collected from normal individuals and 
mixed with 3.8% trisodium citrate in a volume ratio of 9:1.A 
volume of 200µLof plasma was added to 100µL of L solution 
of different concentrations and 300 µL of CaCl2 (25 mM), and 
the mixture was incubated at 37ºC in a water bath. The time 
of clot formation was recorded with a stopwatch [23]. The 
anticoagulant drug; Heparin was used as standard. 
3. RESULTS AND DISCUSSION 
3.1. Characterization  
The Schiff base L has been prepared according to a 
procedure published by Charef et al. [16] which involve 
condensation of diethylenetriamine with 2’-
hydroxyacetophenone in a 2:1 M ratio. The reaction gave rise 
to the desired Schiff base 2-[(1E)-N-{2-[(2-{(Z)-[1-(2-
hydroxyphenyl) ethylidene]amino}ethyl)amino] 
ethyl}ethanimidoyl]phenol (L) as a yellow solid in 98%. M.p. 
93-94 ºC (lit.105ºC). Rf  = 0.88 (ethyl acetate: ethanol, 7:3 was 
used as mobile phase). The prepared Schiff base has been 
characterized by elemental analysis and by a panel of 
spectroscopic techniques such as Ft-IR, 1H- and 13C-NMR, and 
mass spectrometry. The data, detailed in the experimental 
section are consistent with the suggested structure. Thus, the 
mass spectra display the correct molecular ion peak for 
which the measured high resolution (HRMS) data are in good 
agreement with the calculated values. DEPT experiments 
were used to distinguish secondary hydrogens from primary 
and tertiary ones. Furthermore, FT-IR and 1H NMR data are 
similar to those reported in the literature [24]. 
3.1.1. IR and UV–Vis spectra 
The IR spectra of the ligand L and the complex (Figure 1), 
revealed the difference between these compounds by the 
absence of the band of azomethine group (1616 cm-1) in IR 
spectra of the complex, and the appears of tow bands at 3276 
and 3243cm-1 of primary NH2. Results indicate the complete 
hydrolysis of the Schiff base ligand L.     
 
Figure 1. IR spectra of L and complex 
The UV-visible spectra of L recorded in ethanol, showed two 
bands at 321 and 389 nm. The first band can be attributed to 
𝜋-𝜋* transition within the aromatic ring, whereas the second 
band could be due to n-𝜋* transition within -C=N group. In 
addition, the UV-visible spectra of the complex recorded in 
distilled water, showed the absence of the precedents bands 
of aromatic ring and( -C=N) group.  
3.1.2. Powder XRD  
Results represented in Figure 2 revealed XRD patterns of the 
complex and demonstrate the sharp crystalline peaks which 
confirmed crystalline phase of the complex; with 2ϴ ranging 
from 0 to 80º.  
 
Figure 2. Powder XRD pattern of the complex 
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3.2. Antioxidant activity 
The antioxidant activity of the synthesized Schiff base ligand 
was investigated in vitro by different methods and through 
the use of various assays. Certainly the use of various 
methods leads to more reliable and satisfactory results [25]. 
The first test was the effect of L against DPPH, which is a free 
radical, used as a model for measuring the antioxidant 
activity. The reaction between antioxidant agents and DPPH, 
allows conversion of latter to the stabilized form (1,1-
diphenyl-2-picrylhydrazine). Stabilization of this radical 
indicates the hydrogen-donating capacities of antioxidants 
[26].Results presented in Figure 7; reveal that scavenging 
activity of L was concentration-dependent. The inhibition 
concentration of 50% (IC50) of DPPH radical was 3.37 ± 0.13 
mg.mL-1 for L and 0.087 ± 0.001 mg/mL for BHT.   In the 
present investigation, the presence of two hydroxyl groups at 
aromatic rings in the L molecule, leads to stabilization of the 
free radicals. This is in agreement with results reported in 
the literature which indicate that molecules with multiple OH 
groups attached at the aromatic ring may have higher free 
radical-scavenging activity [27]. In addition, the antioxidant 
capacity of L was evaluated against free radicals formed in 
linoleic acid oxidation. Results displayed in Figure 8, show 
that L can inhibit the oxidation of β-carotene after a reaction 
time of 2 h with inhibition percentage of 59.07%. The effect 
of L against lipid peroxidation was studied and results are in 
agreement those previously obtained Charef et al. [16] and 
by Zai-Qun [28], who showed the importance of hydroxyl-
substituted Schiff bases in the protection against radical-
induced peroxidation of triolein in micelles, hemolysis of 
human red cells, and oxidation of DNA. 
The powerful reactivity of hydroxyl radicals causes higher 
interaction with biomolecules and can easily cross 
biomembranes and causes cell damage [29]. Detection of OH• 
is achieved by the hydroxylation of salicylate in the system of 
Fenton reaction (presence of FeSO4 and H2O2). Displayed in 
Figure 9 are results related to the scavenging activity of L 
against hydroxyl radicals, with an IC50 of 116.52µg/mL.  
Results agree with previous studies. [30], which proved that 
good electron donors may accelerate the conversion of H2O2 
to H2O. The presence of active hydrogen (in a phenolic 
group) could be responsible for the scavenging activity of L. 
On the other hand, the ABTS radical cation assay was used to 
confirm the free radical-scavenging activity. Results showing 
the ABTS radical scavenging activity of L, expressed as 
percent inhibition (I%), are displayed in Figure 10. These 
results reveal significant scavenging activity of L with an 
IC50= 22.8 µg/mL, where IC50 of the standard (BHT) is 10.74 
µg/mL. 
To evaluate the reductive capacity of the Schiff base L, the 
effect toward the transformation of Fe3+ to Fe2+ was 
investigated. Results that express the reducing power of the 
prepared Schiff base are shown in Figure 11. Results 
indicate low capacity of L for Fe3+→Fe2+ transformation with 
an IC50 of 3.02 mg/mL. In this assay, the reducing power of a 
tested substance may serve as a significant indicator for its 
potential antioxidant activity [31]. All of these results, 
confirmed the reducing character of the ligand L predicted 
by the theoretical calculations. 
 
 
Figure 7. DPPH radical scavenging activity of L and BHT.  
 
Figure 8. Kinetics of bleaching of β-carotene at 470 nm of 
L, BHT and methanol during 2 h.  
 
Figure 9. OH• scavenging activities of L and ascorbic acid. 
 
Figure 10. Radical scavenging activity L and BHT against 
ABTS. 
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Figure 11. Reducing power assay of L and BHT. 
3.3. Anticoagulant activity 
Anticoagulant agents play an important role in the 
prevention and the treatment of thromboembolic disorders 
[32]. An investigation by Sawant et al. [33] showed that 
Schiff bases display anticoagulant activity. The effect of L on 
plasma recalcification time is depicted in Figure 12. Results 
show the ability of L to prolong the time of coagulation in 
plasma. The normal recalcification time was 5.53 min; the 
recalcification time was prolonged to 12.23 min with the 
increase of concentration (84 µg/mL), which is comparable 
with that the anticoagulant drug (heparin 15.13 min at 38.13 
µg/mL). Our results, are in good agreement with those of 
Sawant et al. [33], who found that most synthesized Schiff 
bases derived from 1,3-Oxazines exhibit significant 
anticoagulant activity by measuring the time taken for the 
clot to form. Our results show that L increases the time of 
recalcification in plasma, which explains the higher 
anticoagulant activity of L. 
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Figure 12. Effect of L and Heparin on plasma 
recalcification time 
4. CONCLUSIONS 
A Schiff base, L, derived from diethylenetriamine and 2’-
hydroxyacetophenone was synthesized and characterized. L 
was hydrolyzed by copper cation. The antioxidant properties 
of L were evaluated by several methods such as DPPH, β-
Carotene bleaching assay, hydroxyl radical scavenging, ABTS 
radical scavenging, and reducing power. Results revealed 
that L has important antioxidant activities. Furthermore, L 
displayed significant anti-recalcification activity. Results 
obtained in the present studies indicate that the ligand L can 
at least be a potential antioxidant and anticoagulant agent. 
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